会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 21. 发明授权
    • Isoprenoid pathway inhibitors for stimulating bone growth
    • 用于刺激骨生长的异戊二醛途径抑制剂
    • US06642216B2
    • 2003-11-04
    • US09848839
    • 2001-05-03
    • Shirley R. GasperRobert R. WestTheresa MartinezKirk G. RobbinsPatricia A. McKernanNand BaindurVirender M. LabrooGregory R. Mundy
    • Shirley R. GasperRobert R. WestTheresa MartinezKirk G. RobbinsPatricia A. McKernanNand BaindurVirender M. LabrooGregory R. Mundy
    • A61K31665
    • C07D215/14A23L33/10A61K31/00A61K31/192A61K31/22A61K31/225A61K31/366A61K31/40A61K31/404A61K31/405A61K31/505A61K45/06A61K2300/00
    • Compounds of the formula wherein X in each of formulas (1) and (2) represents a substituted or unsubstituted alkylene, alkenylene, or alkynylene linker of 2-6C; Y is of the formula  or a stereoisomer thereof, wherein R1 is substituted or unsubstituted alkyl; each R2 is independently H, hydroxy, alkoxy (1-6C) or lower alkyl (1-4C); R3 is H, hydroxy, or alkoxy (1-6C); or Y is of the formula  wherein each n is 1, Z is N, K comprises a substituted or unsubstituted aromatic carbocyclic or heterocyclic ring system which may optionally be spaced from the linkage position shown in formula (7) by a linker of 1-2C, or in formula (7), Z may be spaced from the carbon bonded to X by ═CR6— wherein R6 is H or linear, branded or cyclic alkyl (1-6C), R5 is H or linear, branched or cyclic alkyl, and R′ represents a cation, H or a substituted or unsubstituted alkyl group of 1-6C, promote bone formation and are thus useful in treating osteoporosis, bone fracture or deficiency, primary or secondary hyperparathyroidism, periodontal disease or defect, metastatic bone disease, osteolytic bone disease, post-plastic surgery, post-prosthetic joint surgery, and post-dental implantation. Also disclosed is a method to identify additional compounds which are inhibitors of enzymes in the isoprenoid scheme especially of HMG-CoA reductase which results in prenylation of proteins and in the synthesis of steroids or of inhibitors of their production which are useful in treating bone disorders.
    • 式(1)和(2)中的式(Ⅳ)化合物表示取代或未取代的2-6C的亚烷基,亚烯基或亚炔基接头; Y为其立体异构体,其中R 1为取代或 每个R 2独立地是H,羟基,烷氧基(1-6C)或低级烷基(1-4C); R 3是H,羟基或烷氧基(1-6C); 或Y是每个n是1的烷基,其中Z是N,K包括取代或未取代的芳族碳环或杂环系统,其可以任选地与式(7)所示的连接位置与1-2C的连接体间隔开,或 在式(7)中,Z可以与通过= CR 6键合到X的碳隔开,其中R 6是H或直链的,有品牌的或环状的烷基(1-6C),R 5是H或 直链,支链或环状的烷基,R'表示1-6个C的阳离子H或取代或未取代的烷基,促进骨形成,因此可用于治疗骨质疏松症,骨折或缺陷,原发性或继发性甲状旁腺功能亢进,牙周病或 缺损,转移性骨病,溶骨性骨病,整形后手术,假体后关节手术和牙后植入术。还公开了一种鉴定作为特异性HMG-CoA的异戊二烯方案中的酶抑制剂的其它化合物的方法 导致蛋白质异戊烯化的还原酶 在合成类固醇或其制备的抑制剂中可用于治疗骨骼疾病。